References

Target trial emulation: a framework for causal inference from observational data

10.1001/jama.2022.21383 · ExternalCitation · doi-reference

Transparent reporting of observational studies emulating a target trial—the TARGET statement

10.1001/jama.2025.13350 · ExternalCitation · doi-reference

Restricted mean survival time as a measure to interpret clinical trial results

10.1001/jamacardio.2017.2922 · ExternalCitation · doi-reference

Demystifying clone-censor-weighting to studying treatment initiation windows: an example using publicly available synthetic medicare claims data

10.1002/pds.70223 · ExternalCitation · doi-reference

Ventilator-associated pneumonia in adults: a narrative review

10.1007/s00134-020-05980-0 · ExternalCitation · doi-reference

The positivity assumption and marginal structural models: the example of warfarin use and risk of bleeding

10.1007/s10654-011-9637-7 · ExternalCitation · doi-reference

Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European society of clinical microbiology and infectious diseases

10.1016/j.cmi.2017.04.011 · ExternalCitation · doi-reference

Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium

10.1016/j.ijantimicag.2013.12.002 · ExternalCitation · doi-reference

Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis

10.1016/j.ijantimicag.2015.09.011 · ExternalCitation · doi-reference

Pulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and formed colistin following nebulisation of CMS among patients with ventilator-associated pneumonia

10.1016/j.ijantimicag.2022.106588 · ExternalCitation · doi-reference

Treatment of infections caused by multidrug-resistant gram-negative bacilli: a practical approach by the italian (SIMIT) and french (SPILF) societies of infectious diseases

10.1016/j.ijantimicag.2024.107186 · ExternalCitation · doi-reference

Competing risk bias was common in kaplan-meier risk estimates published in prominent medical journals

10.1016/j.jclinepi.2015.07.006 · ExternalCitation · doi-reference

Kaplan-meier survival analysis overestimates cumulative incidence of health-related events in competing risk settings: a meta-analysis

10.1016/j.jclinepi.2017.10.006 · ExternalCitation · doi-reference

Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis

10.1016/j.jclinepi.2020.03.004 · ExternalCitation · doi-reference

Effectiveness and safety of adjunctive inhaled antibiotics for ventilator-associated pneumonia: a systematic review and meta-analysis of randomized controlled trials

10.1016/j.jcrc.2021.06.004 · ExternalCitation · doi-reference

Nebulized colistin as the adjunctive treatment for ventilator-associated pneumonia: a systematic review and meta-analysis

10.1016/j.jcrc.2023.154466 · ExternalCitation · doi-reference

Intravenous plus inhaled versus intravenous colistin monotherapy for lower respiratory tract infections: a systematic review and meta-analysis

10.1016/j.jinf.2018.02.002 · ExternalCitation · doi-reference

Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma

10.1016/s0091-6749(97)70219-7 · ExternalCitation · doi-reference

Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies

10.1016/s1473-3099(13)70081-1 · ExternalCitation · doi-reference

Inhaled colistimethate sodium in patients with bronchiectasis and pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months

10.1016/s2213-2600(24)00225-x · ExternalCitation · doi-reference

Aerosol delivery during invasive mechanical ventilation: development of a preclinical ex vivo respiratory model for aerosol regional deposition

10.1038/s41598-019-54480-9 · ExternalCitation · doi-reference

Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications

10.1046/j.1365-2125.2003.01892.x · ExternalCitation · doi-reference

The effects of airway disease on the deposition of inhaled drugs

10.1080/17425247.2024.2392790 · ExternalCitation · doi-reference

Constructing inverse probability weights for marginal structural models

10.1093/aje/kwn164 · ExternalCitation · doi-reference

Using big data to emulate a target trial when a randomized trial is not available

10.1093/aje/kwv254 · ExternalCitation · doi-reference

Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections

10.1093/cid/ciae403 · ExternalCitation · doi-reference

Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic Society

10.1093/cid/ciw353 · ExternalCitation · doi-reference

Competing risks analyses: objectives and approaches

10.1093/eurheartj/ehu131 · ExternalCitation · doi-reference

Reflection on modern methods: trial emulation in the presence of immortal-time bias. Assessing the benefit of major surgery for elderly lung cancer patients using observational data

10.1093/ije/dyaa057 · ExternalCitation · doi-reference

Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by gram-negative bacteria

10.1093/jac/dkq360 · ExternalCitation · doi-reference

Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men

10.1097/00001648-200009000-00012 · ExternalCitation · doi-reference

The role of aerosolized colistin in the treatment of ventilator-associated pneumonia: a systematic review and metaanalysis

10.1097/ccm.0000000000000771 · ExternalCitation · doi-reference

Treatment with inhaled antibiotics in bronchiectasis, side effects, and evaluation of the tolerance test; analysis from the BATTLE randomized controlled trial

10.1111/crj.13663 · ExternalCitation · doi-reference

Bias by censoring for competing events in survival analysis

10.1136/bmj-2022-071349 · ExternalCitation · doi-reference

How to estimate the effect of treatment duration on survival outcomes using observational data

10.1136/bmj.k182 · ExternalCitation · doi-reference

Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size

10.1164/rccm.200410-1414oc · ExternalCitation · doi-reference

Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit

10.1164/rccm.201312-2161oc · ExternalCitation · doi-reference

European respiratory society clinical practice guideline for the management of adult bronchiectasis

10.1183/13993003.01126-2025 · ExternalCitation · doi-reference

Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome

10.1186/1471-2288-13-152 · ExternalCitation · doi-reference

Evaluating mortality in intensive care units: contribution of competing risks analyses

10.1186/cc3921 · ExternalCitation · doi-reference

Estimating restricted mean survival time and expected life-years lost in the presence of competing risks within flexible parametric survival models

10.1186/s12874-021-01213-0 · ExternalCitation · doi-reference

Fundamentals of aerosol therapy in critical care

10.1186/s13054-016-1448-5 · ExternalCitation · doi-reference

Aerosol delivery during invasive mechanical ventilation: a systematic review

10.1186/s13054-017-1844-5 · ExternalCitation · doi-reference

Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns

10.1186/s41479-022-00096-z · ExternalCitation · doi-reference

Bronchodilator pretreatment improves aerosol deposition uniformity in HIV-positive patients who cough while inhaling aerosolized pentamidine

10.1378/chest.106.2.421 · ExternalCitation · doi-reference

A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD

10.1378/chest.98.4.835 · ExternalCitation · doi-reference

Target trial emulation to improve causal inference from observational data: what, why, and how?

10.1681/asn.0000000000000152 · ExternalCitation · doi-reference

The distribution of multidrug-resistant microorganisms and treatment status of hospital-acquired pneumonia/ventilator-associated pneumonia in adult intensive care units: a prospective cohort observational study

10.3346/jkms.2021.36.e251 · ExternalCitation · doi-reference

Intrapulmonary and systemic pharmacokinetics of colistin following nebulization of low-dose colistimethate sodium in patients with ventilator-associated pneumonia caused by carbapenem-resistant acinetobacter baumannii

10.3390/antibiotics13030258 · ExternalCitation · doi-reference

High-loading-dose colistin with nebulized administration for carbapenem-resistant Acinetobacter baumannii pneumonia in critically ill patients: a retrospective cohort study

10.3390/antibiotics13030287 · ExternalCitation · doi-reference

In vitro and in silico evaluation of polymyxin B aerosol delivery in adult mechanical ventilation

10.3390/pharmaceutics18010058 · ExternalCitation · doi-reference

Target trial emulation: a concept simply explained

10.4088/jcp.25f15796 · ExternalCitation · doi-reference